Obama Thinks "Precision Medicine" Will Make Us Healthier. Experts are Skeptical.
By Julia Belluz,
Vox
| 01. 30. 2015
Untitled Document
The White House is committing $215 million to support efforts to develop personalized medicine, a priority the President touched on in his State of the Union earlier this month.
At the time, the details weren't clear. But today the White House released more information on the "precision medicine initiative," which has bipartisan support: it would get started with a $215 million cash injection from the 2016 federal budget to support everything from the building databases at the National Institutes of Health to study the genetic bases of disease, to applying that knowledge to targeted cancer therapeutics and public health.
"Most medical treatments have been designed for the 'average patient,'" the White House statement read. "As a result of this 'one-size-fits-all-approach,' treatments can be very successful for some patients but not for others."
The only problem is that this is much, much harder than it sounds.
Precision medicine — also known as personalized or individualized medicine — has been one of the big, unmet promises in health care for a long time. Hank Greely, a law professor at Stanford...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...